More recently, we also reported that the nuclear PKM2 interacts directly with P53 protein and inhibits P53-dependent transactivation of the P21 gene, leading to a nonstop G1 phase in cancer cells exposed to DNA-damaging agent [27]. The gene discussed is PKM; the disease is cancer.